Marianne Uteng works as a Managing Director at Novartis. The firm's known portfolio counts 16 companies.
Is Marianne Uteng a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiotechCell & Gene TherapyDiagnosticsDrug DiscoveryGenomicsImmunologyMedTechOncologyPharma
Contacts
Affiliated funds' portfolios
Managing Director at Novartis, whose known portfolio counts 16 companies
- Octave
- Vor Biopharma
- Patientory
- Orna Therapeutics
- Pliant Therapeutics
- TScan Therapeutics
- CatalYm
- Dren Bio
- Surface Oncology
- Cadent Therapeutics
- Flare Therapeutics
- Medtech Africa
- and 4 more
Investor Profile
Marianne Uteng is listed against sector Healthcare, and focus areas Biotech, Cell & Gene Therapy, Diagnostics and Drug Discovery in the database.
Novartis appears in Growth, Seed and Series A rounds across its known deals.
The firm portfolio and the focus above give founders context on whether Marianne Uteng matches their raise.
Colleagues at Novartis
Paolo Malerba
Strategy Lead
London, United Kingdom
Jose Marcilla
President Latin America and Canada (LACan) Region
United States
Beat Steffen
Managing Director Novartis Venture Fund
Basel, Switzerland
Anja König
Global Head Novartis Venture Fund
Basel, Switzerland
Jason Freeman
Senior Medical Director
Washington, United States
Shejoy Varghese
Managing partner
Ernakulam, India
Marc Ceulemans
Head, Strategic Venture Capital Fund
Laax, Switzerland
Md. Sohel Rana
Managing Partner
Bangladesh
Steven Breazzano
Investor
Fairfield, United States
Lauren Silverman
Managing Director
Cambridge, United States
Stefanie D.
Portfolio Reporting Director
Zürich, Switzerland
Frequently asked questions
Who is Marianne Uteng?
Marianne Uteng is a corporate venture investor based in Basel, Switzerland, listed as Managing Director at Novartis. The known portfolio of that firm counts 16 companies. That portfolio belongs to the firm, not to Marianne Uteng personally.
What does Marianne Uteng invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Cell & Gene Therapy, Diagnostics and Drug Discovery. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Marianne Uteng invest at?
Novartis appears in Growth, Seed and Series A rounds across its known deals, and Marianne Uteng is listed there as Managing Director. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Marianne Uteng listed at?
Marianne Uteng is listed as Managing Director at Novartis. 11 other people in the database share a firm with Marianne Uteng.
How do I contact Marianne Uteng?
An email address, a phone number and a LinkedIn page are on file for Marianne Uteng. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal